$-0.45
(Market cap
$95 Mln
Revenue (TTM)
$26 Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
46,288,600
10 Years Aggregate
CFO
$-226.60 Mln
EBITDA
$-221.49 Mln
Net Profit
$-291.51 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
| -50.2 | -20.7 | -49.8 | -12.3 | -54.4 | -29.5 | -- |
|
BSE Sensex*
| -11.7 | -2.7 | -8.0 | -8.0 | 6.2 | 7.8 | 10.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
| 55.6 | -84.3 | -46.9 | 64.3 | 57.2 | -63.3 | -64.0 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aadi Bioscience (AADI)
|
1.6 | 94.9 | 26.0 | -63.7 | -247.1 | -80.8 | -- | 1.4 |
| 41.0 | 5,252.7 | 1,105.3 | 133.3 | 15.9 | 32.7 | 38.3 | 12.7 | |
| 234.5 | 12,066.3 | 708.2 | -188.3 | -25.6 | -293.5 | -- | 221.1 | |
| 66.3 | 12,977.8 | 580.0 | -725.9 | -105.2 | -- | -- | 123.7 | |
| 69.5 | 7,459.9 | 769.1 | 47.9 | 5.4 | 7.5 | 198.5 | 11.2 | |
| 13.6 | 11,337.9 | 353,471.6 | 45,087.2 | 16.1 | 12.8 | 25.6 | 2.9 | |
| 23.9 | 11,832.0 | 4,893.0 | -242.0 | -1.5 | -3.7 | -- | 1.8 | |
| 7.9 | 5,342.5 | 7,447.6 | 415.6 | 16.2 | 6.6 | 11.1 | 0.9 | |
| 232.0 | 4,648.7 | 274.5 | 153.6 | 76.6 | 15.8 | 30.2 | 4.7 | |
| 61.9 | 5,501.1 | 288.1 | 22.3 | 17.5 | 34.1 | 363.9 | 50.5 |
Shareholding Pattern
View DetailsAbout Aadi Bioscience (AADI)
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of... sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California. Read more
-
Founder, Secretary & Executive Chairman
Dr. Neil P. Desai Ph.D.
-
Founder, Secretary & Executive Chairman
Dr. Neil P. Desai Ph.D.
-
Headquarters
Pacific Palisades, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Aadi Bioscience (AADI)
What is the current share price of Aadi Bioscience Inc (AADI) Today?
The share price of Aadi Bioscience Inc (AADI) is $1.57 (NASDAQ) as of 17-Apr-2025 09:30 EDT. Aadi Bioscience Inc (AADI) has given a return of -54.36% in the last 3 years.
What is the current PB & PE ratio of Aadi Bioscience Inc (AADI)?
Since, TTM earnings of Aadi Bioscience Inc (AADI) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
What is the 52 Week High and Low of Aadi Bioscience Inc (AADI)?
The 52-week high and low of Aadi Bioscience Inc (AADI) are Rs -- and Rs -- as of 01-Jun-2026.
What is the market cap of Aadi Bioscience Inc (AADI)?
Aadi Bioscience Inc (AADI) has a market capitalisation of $ 95 Mln as on 17-Apr-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Aadi Bioscience Inc (AADI)?
Before investing in Aadi Bioscience Inc (AADI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.